Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,786 | 34,737 | 59,403 | 105,973 | 42,107 |
| Receivables | 44,350 | 39,223 | 34,753 | 62,971 | 42,744 |
| Inventories | 11,712 | 13,469 | 25,398 | 518 | 3,412 |
| TOTAL | $94,254 | $104,492 | $135,463 | $180,113 | $103,951 |
| Non-Current Assets | |||||
| PPE Net | 2,437 | 3,773 | 7,349 | 3,233 | 3,497 |
| Investments And Advances | 0 | 0 | 1,579 | 8,132 | 13,064 |
| Intangibles | 200,082 | 215,636 | 193,863 | 23,671 | 400,535 |
| Other Non-Current Assets | 6,501 | 8,896 | 7,470 | 4,125 | 6,123 |
| TOTAL | $209,020 | $228,305 | $210,261 | $39,161 | $423,219 |
| Total Assets | $303,274 | $332,797 | $345,724 | $219,274 | $527,170 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,942 | 11,010 | 7,374 | 57,866 | 80,000 |
| Accounts payable and accrued liabilities | 14,808 | 28,810 | 31,289 | 5,286 | 24,568 |
| Accrued Expenses | 91,978 | 81,994 | 84,004 | 57,075 | 77,891 |
| Other current liabilities | 13,958 | 9,560 | 11,705 | 2,066 | 2,094 |
| TOTAL | $132,686 | $131,374 | $134,372 | $122,293 | $184,553 |
| Non-Current Liabilities | |||||
| Long Term Debt | 72,160 | 77,235 | 91,834 | N/A | 271,258 |
| Other Non-Current Liabilities | 42,914 | 48,238 | 34,540 | 12,944 | 13,401 |
| TOTAL | $115,074 | $125,473 | $126,374 | $12,944 | $284,659 |
| Total Liabilities | $247,760 | $256,847 | $260,746 | $135,237 | $469,212 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,892 | 1,788 | 1,786 | 1,357 | 1,355 |
| Common Shares | 3 | 12 | 11 | 8 | 8 |
| Retained earnings | -427,945 | -403,592 | -393,070 | -358,571 | -399,801 |
| TOTAL | $55,514 | $75,950 | $84,978 | $84,037 | $57,958 |
| Total Liabilities And Equity | $303,274 | $332,797 | $345,724 | $219,274 | $527,170 |